AVITA Medical Reports First Quarter Financial Results
May 13, 2024 16:01 ET
|
AVITA Medical
AVITA Medical (NASDAQ: RCEL, ASX: AVH) today reported financial results for the first quarter ended March 31, 2024.
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
May 13, 2024 16:01 ET
|
Allogene Therapeutics, Inc.
Cemacabtagene Ansegedleucel (Cema-Cel) Expanded CD19 Oncology Rights to Include all EU Member States and the United Kingdom, Reinforcing Company’s Conviction in the Unique Opportunity in Large B Cell...
Assure & Danam to Host Corporate Update Call & Webcast
May 13, 2024 16:01 ET
|
Assure Holdings Corp.
DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services,...
Teknova Reports First Quarter 2024 Financial Results
May 13, 2024 16:01 ET
|
Alpha Teknova, Inc.
First quarter 2024 total revenue was $9.3 million, up 2% from prior yearLaunch of Build-Tek™ Custom ConfiguratorCompany reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., May 13,...
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
May 13, 2024 16:01 ET
|
Vaxart, Inc.
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants ...
Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13, 2024 16:01 ET
|
Invivyd
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced...
Aprea Therapeutics to Attend the 2024 RBC Capital Markets Global Healthcare Conference
May 13, 2024 16:01 ET
|
Aprea Therapeutics
DOYLESTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through...
Cara Therapeutics Reports First Quarter 2024 Financial Results
May 13, 2024 16:01 ET
|
Cara Therapeutics, Inc.
STAMFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of...
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
May 13, 2024 16:01 ET
|
Voyager Therapeutics, Inc.
- Company announces clearance of IND application with FDA for anti-tau antibody VY-TAU01 for the treatment of Alzheimer’s disease; expect to begin single ascending dose trial in the coming weeks - -...
Slate Market Size to Surpass US$ 1,657.02 Million by 2033, The Brainy Insights
May 13, 2024 16:00 ET
|
The Brainy Insights
Newark, May 13, 2024 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global slate market is expected to grow from USD 1,005.71 Million in 2023 to USD 1,657.02 Million by...